Skip to main content

Myeloperoxidase assay

BRD ID: 2028
Tier: SOP
Source: TCP Project
Document: BARC PRO 019 Myeloperoxidase.pdf[Size: 4952.18 KB]
Number of times downloaded: 717

Description

This document describes the protocol used by the Pathology and Laboratory Medicine Department of Boston Medical Center (BMC) to quantify levels of myeloperoxidase (MPO) in plasma by ELISA as part of the Thrombosis in Cancer Patients (TCP) Project. It is a product of the Center for Strategic Scientific Initiatives (CSSI) of the National Institutes of Health (NIH) (https://www.cancer.gov/about-nci/organization/cssi/research/past-programs#thrombosis-in-cancer-standardization-of-biomarker-measurements).